Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines
Ai‐ris Y. Collier, Jingyou Yu, Katherine McMahan, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 21, pp. 2010-2012
Open Access | Times Cited: 177

Showing 26-50 of 177 citing articles:

Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 9
COVID-19 vaccines: Immune correlates and clinical outcomes
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh
Md. Ahsanul Haq, Anjan Kumar Roy, Razu Ahmed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
Lei Li, Yoshikazu Honda‐Okubo, Jeremy Baldwin, et al.
Vaccine (2022) Vol. 40, Iss. 23, pp. 3182-3192
Open Access | Times Cited: 36
Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign
Theodore Lytras, Flora Kontopidou, Angeliki Lambrou, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 5044-5050
Open Access | Times Cited: 34
COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review
Emily Drzymalla, Ridgely Fisk Green, Martha Knuth, et al.
Clinical Immunology (2022) Vol. 243, pp. 109097-109097
Open Access | Times Cited: 34
Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective
Chunlan Zhuang, Xiaohui Liu, Qi Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 33
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 31
Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102424-102424
Open Access | Times Cited: 30
Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
Zhonghao Chen, Ying Zhang, Meng Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4629-4641
Open Access | Times Cited: 30
SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical Center
Luba Tau, Dan Turner, Amos Adler, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 4
Open Access | Times Cited: 28
Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults
Lior Rennert, Zichen Ma, Christopher S. McMahan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
Astrid Korning Hvidt, Eva Anna Marianne Baerends, Ole S. Søgaard, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 28
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques
Laura Solforosi, L M M Costes, Jeroen Tolboom, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study
Wataru Akahata, Takashi Sekida, Takuto Nogimori, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101134-101134
Open Access | Times Cited: 18
COVID-19 Associated Cardiovascular Disease—Risks, Prevention and Management: Heart at Risk Due to COVID-19
Andrew Kemerley, Abhishek Gupta, Mahesh Thirunavukkarasu, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 1904-1920
Open Access | Times Cited: 5
A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
Yadira Pastor, Olivier Reynard, Mathieu Iampietro, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101467-101467
Open Access | Times Cited: 5
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective
Yuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment
Yonger Xue, Xucheng Hou, Yichen Zhong, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal Study
Sanjeeb Kumar Mishra, Subrat Kumar Pradhan, Sanghamitra Pati, et al.
Cureus (2021)
Open Access | Times Cited: 34
Immunizing the imperfect immune system
Jessica Durkee-Shock, Michael D. Keller
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 5, pp. 562-571.e1
Open Access | Times Cited: 26
Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers – ORCHESTRA project
Giulia Collatuzzo, Giovanni Visci, Francesco Saverio Violante, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
R. Medhat, Rania M. El-Lababidi, Manal Abdel-Salam, et al.
International Journal of Infectious Diseases (2022) Vol. 119, pp. 184-186
Open Access | Times Cited: 25
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials
Jerald Sadoff, Mathieu Le Gars, Boerries Brandenburg, et al.
Vaccine (2022) Vol. 40, Iss. 32, pp. 4403-4411
Open Access | Times Cited: 24
The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
Zhongjie Sun, Tingxin Wu, Huangfan Xie, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1103-1103
Open Access | Times Cited: 24

Scroll to top